Common peroneal nerve palsy following TNF-based isolated limb perfusion for irresectable extremity desmoid tumor

Orthopaedics and Traumatology: Surgery and Research

Volumn 95, Issue 8, 2009, Pages 639-644

  Drouet, A ^a   Le Moigne, F ^a   Have, L ^a   Blondet, R ^b   Jacquin, O ^a   Chauvin, F ^a  

^a Desgenettes Military Teaching Hospital   (France)

^b CENTRE LÉON BÉRARD   (France)

Author keywords

Common peroneal nerve; Desmoid tumor; Isolated limb perfusion; Melphalan; Neural damage; TNF alpha

Indexed keywords

MELPHALAN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CASE REPORT; DESMOID TUMOR; DISEASE SEVERITY; EDEMA; ELECTROMYOGRAPHY; FASCIOTOMY; FOLLOW UP; HUMAN; LIMB PERFUSION; MALE; NEURECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL NERVE INJURY; PERONEUS NERVE PARALYSIS; PHLEBITIS; PRIORITY JOURNAL; RADIUM THERAPY; REOPERATION; TUMOR RECURRENCE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; ELECTROMYOGRAPHY; FIBROMATOSIS, AGGRESSIVE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MELPHALAN; MIDDLE AGED; NEOPLASM STAGING; PARALYSIS; PERONEAL NERVE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SOFT TISSUE NEOPLASMS; THIGH; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 71249092485     PISSN: 18770568     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otsr.2009.09.009     Document Type: Article

References (16)

1. Creech O., Krementz E.T., Ryan R.F., and Winblad J.N. Chemotherapy of cancer: Regional perfusion utilizing an extracorporeal circuit. Ann Surg 148 (1958) 616-632
2. Lev-Chelouche D., Abu-Abeid S., Nakache R., Issakov J., Kollander Y., Mérimsky O., et al. Limb desmoid tumors: A possible role for isolated limb perfusion with tumor necrosis factor-alpha and melphalan. Surgery 126 (1999) 963-967
3. Grünhagen D.J., De Wilt J.H., Verhoef C., Van Geel A.N., and Eggermont A.M. TNF-based isolated limb perfusion in unresectable extremity desmoid tumours. Eur J Surg Oncol 31 (2005) 912-916
4. Wieberdink J., Benckhuijsen C., Braat R.P., Van Slooten E.A., and Olthuis G.A.A. Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions. J Cancer Clin Oncol 18 (1982) 905-910
5. Pakos E.E., Tsekeris P.G., and Goussia A.C. Desmoid tumours of the extremities and trunk: a review of the literature. Int Orthop 29 (2005) 210-213
6. Hattoma N., Largab A., Kafih M., Rafai M., Maher N., and Trahef M. Desmoid tumors of the shoulder-girdle (report of three cases). Chir Main 23 (2004) 184-189
7. Cheon S.S., Cheah A.Y., Turley S., Nadesan P., Poon R., Clevers H., et al. Beta-Catenin stabilization dysregulates mesenchymal cell proliferation, motility, and invasiveness and causes aggressive fibromatosis and hyperplastic cutaneous wounds. Proc Natl Acad Sci U S A 99 (2002) 6973-6978
8. Baumert B.G., Spahr M.O., Von Hochstetter A., Beauvois S., Landmann C., Fridrich K., et al. The impact of radiotherapy in the treatment of desmoid tumours. An international survey of 110 patients. A study of the rare cancer network. Radiat Oncol 2 (2007) 1-12
9. Lejeune F.J., Lienard D., El Douhaihy M., Seyedi J.V., and Ewalenko P. Results of 206 isolated limb perfusions for malignant melanoma. Eur J Surg Oncol 15 (1989) 510-519
10. Kettelhack C., Kraus T., Hupp T., Manner M., and Schlag P. Hyperthermic limb perfusion for malignant melanoma and soft tissue sarcoma. Eur J Surg Oncol 16 (1990) 370-375
11. Vrouenraets B.C., Eggermont A.M., Klaase J.M., Van Geel B.N., Van Dongen J.A., and Kroon B.B. Long-term neuropathy after regional isolated perfusion with melphalan for melanoma of the limbs. Eur J Surg Oncol 20 (1994) 681-685
12. Vrouenraets B.C., Eggermont A.M., Hart A.A., Klaase J.M., Van Geel B.N., Nieweg O.E., et al. Regional toxicity after isolated limb perfusion with melphalan and tumor necrosis factor-alpha versus toxicity after melphalan alone. Eur J Surg Oncol 27 (2001) 390-395
13. Knorr C., Meyer T., Janssen T., Goehl J., and Hohenberger P. Hyperthermic isolated limb perfusion (HILP) in malignant melanoma. Experience with 101 patients. Eur J Surg Oncol 32 (2006) 224-227
14. Grünhagen D.J., De Wilt J.H., Graveland W.J., Van Geel A.N., and Eggermont A.M. The palliative value of tumor necrosis factor alpha-based isolated limb perfusion in patients with metastatic sarcoma and melanoma. Cancer 106 (2006) 156-162
15. Hohenberger P., Finke L.H., and Schlag P.M. Intracompartmental pressure during hyperthermic isolated limb perfusion for melanoma and sarcoma. Eur J Surg Oncol 22 (1996) 147-151
16. Rydevik B., Lundborg G., and Bagge U. Effects of graded compression on intraneural blood flow: an in vivo study on rabbit tibial nerve. J Hand Surg 63 (1981) 3-9